The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...

The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software.

Vicarious Surgical has delayed the clinical timeline for its surgical robot, having previously stated it would initiate first ...

Reprieve Cardiovascular has closed an oversubscribed Series B financing round, raising $61m, for the trial of the Reprieve ...

The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas ...

Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.

Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...

The SEMR JV between Interventional Systems and HICREN has obtained approval for the Intelligent SpinePecker spinal surgical ...

HeartFlow’s $364m initial public offering (IPO) signals market validation for the use artificial intelligence (AI) in a ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific’s Oncomine Dx Target Test as a treatment for non-small cell lung cancer (NSCLC). The test serves as a ...

On 8 August, the US Food and Drug Administration (FDA) granted accelerated approval to Hernexeos (zongertinib) - a human epidermal growth factor receptor 2 (HER2) selective tyrosine kinase inhibitor - ...